China issues complaint to UN about Elon Musk
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
Neuralink, the US neurotechnology firm co-founded by the billionaire entrepreneur, has begun recruiting key employees to run clinical trials for the brain chip to wire human brains to computers. These include clinical trial director and clinical trial coordinator, with job ads that mention the company’s “first clinical trial participants.”
Mr Musk and his Neuralink partners founded the company in 2016 to develop brain chips that connect humans with computers.
He has claimed that the implants will enable paralyzed people to control such devices as smartphones with their brains.
His company aims to provide solutions for many physical disabilities by bridging signals between neurons, once human testing begins.
The company publicly demonstrated the power of its technology last April, when it posted footage that claimed to show a monkey playing a video game with its mind.
The chips have been tested in the brains of a macaque monkey and a pig.
Speaking at the Wall Street Journal CEO Council summit last month, Mr Musk said the first human test subjects will be people with severe spinal injuries such as quadriplegics.
He said: “We have a chance with Neuralink to restore full-body functionality to someone who has a spinal cord injury.”
The newly posted adverts for his company state that new employees will “work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink’s first clinical trial participants.”
The director, states the ad, will build the clinical research team and will develop “regulatory interactions that come with a fast-paced and ever-evolving environment.”
Mr Musk is ranked as the world’s richest person, with a fortune estimated at $256 billion.
He stated last month that he expects to have Neuralink brain chips implanted in humans sometime in 2022.
He will need to wait for approval from the US Food and Drug Administration (FDA).
This comes after claims that a paralyzed man Philip O’Keefe was able to send a tweet using only his mind using a similar technology.
The 62-year-old Australian has been diagnosed with amyotrophic lateral sclerosis (ALS) – a disease that causes paralysis.
However, he is now able to communicate thoughts with others with no muscle activity involved, claim the leading brain-computer interface company Synchron that made it possible.
DON’T MISS: Diabetes ‘wonder-drug’ stuns scientist as it’s linked with anti-ageing [INSIGHT]
Chinese zodiac signs: What your animal says about you [ANALYSIS]
‘Better than sleeping pills!’ Aldi shoppers go wild for new tea item [BREAKING]
The tweet, which was posted on the company’s CEO’s Twitter account but claimed to be from Mr O’Keefe, read: “No need for keystrokes or voices.
“I created this tweet just by thinking it.”
The implant, “designed to enable patients to wirelessly control digital devices through thought,” was inserted via the jugular vein to avoid drilling into the skull.
Synchron reported that Mr O’Keefe said – or thought: “Now, I just think about where on the computer I want to click, and I can email, bank, shop, and now message the world via Twitter,”
He added that the “astonishing” system takes practice, just like learning to ride a bike, “but once you’re rolling, it becomes natural.”
Source: Read Full Article
